Longpre Lara 4/A
4/A · Mirum Pharmaceuticals, Inc. · Filed Mar 8, 2021
Insider Transaction Report
Form 4/AAmended
Longpre Lara
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2021-01-07+65,000→ 65,000 totalExercise: $19.19Exp: 2031-01-06→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]This Form 4 is being amended to correct the transaction date.
- [F2]1/4th of the shares vest one year after January 7, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.